Immunogen
UEI: GPE8PCA3MKZ3
• CAGE: 61CM8
Overview
Parent Awardee
Company Description
Target a better now with ImmunoGen, Inc., a biotechnology company focused on the development of antibody-drug conjugate (ADC) technology to treat cancer.
Name
Immunogen
Website
Headquarters
Waltham, MA
United States
United States
Federal recipient
IMMUNOGEN INC
(UEI GPE8PCA3MKZ3, CAGE 61CM8)
is headquartered in Waltham MA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in March 1981 and
federally registered in
June 2010.
Federal Registration and Certifications
Legal Name
IMMUNOGEN INC
UEI
GPE8PCA3MKZ3
CAGE Code
61CM8
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 1, 1981
Initial Registration
June 10, 2010
Last Registration
Oct. 18, 2024
Registration Activation
July 10, 2024
Registration Expiration
July 9, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
MA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No